AzurRx BioPharma Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.86 |
Market Cap |
$30.54 M |
Shares Outstanding |
21.06 M |
Public Float |
11.13 M |
Address |
760 Parkside Avenue Brooklyn New York 11226 United States |
Employees | - |
Website | http://www.azurrx.com |
Updated | 07/08/2019 |
AzurRx BioPharma, Inc. is a development stage company, which engages in the research and development of non-systemic biologics for the treatment of patients with gastrointestinal disorders. It offers MS1819 and AZX1101 that are therapeutic proteins products under development. The company was founded on January 30, 2014 and is headquartered in Brooklyn, NY. |